BioSpace News Archive

Novocure announced that it will participate in two upcoming investor conferences.

Kyros Law announces that the brain of former professional wrestler Frederick Seawright (better known as Brickhouse Brown) is being studied for CTE.

vTv Therapeutics Inc. reported financial results for the second quarter that ended June 30, 2018, and provided an update on recent achievements and upcoming events.

Low Levels of Fatty Acids Associated with Preterm Birth, Danish Study Finds

CRH Medical Corporation announces that it will participate in the 2018 Canaccord Genuity Growth Conference at the Intercontinental Hotel in Boston, Massachusetts.

CompactCath has announced the expansion of its intermittent urinary catheter product line with the addition of CompactCath® Coudé and OneCath®.

Tandem Diabetes Care Inc. (NASDAQ: TNDM) (“Tandem”), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the pricing of an underwritten public offering of 3,508,770 shares of its common stock at a price to the public of $28.50 per share.

Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.

Data Include Updates from Phase 2/3 Starbeam (ALD-102) Study of Lenti-D for Cerebral Adrenoleukodystrophy (CALD) and Initial Data from Ongoing Observational Study (ALD-103) of Allogeneic Hematopoietic Stem Cell Transplant for CALD

Calculus Capital, the award-winning Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist, has invested £2m in Oxford BioTherapeutics (OBT), a clinical-stage oncology company that is developing next-generation cancer treatments.